Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-033148
Filing Date
2022-10-06
Accepted
2022-10-06 16:15:39
Documents
1
Period of Report
2022-10-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 39010
  Complete submission text file 0000899243-22-033148.txt   40410
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Choi Jung (Reporting) CIK: 0001650126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 221298329